59 related articles for article (PubMed ID: 37243310)
1. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
[TBL] [Abstract][Full Text] [Related]
2. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.
Chan N; Einstein AJ; Griffin JM; Rosenblum H; Teruya S; Cuomo M; De Los Santos J; DeLuca A; Johnson LL; Kinkhabwala MP; Leb JS; Mintz A; Fine D; Helmke S; Muralidhar V; Pandey S; Sabogal N; Saith SE; Winburn M; Smiley D; Miller EJ; Ruberg FL; Maurer MS
J Nucl Cardiol; 2023 Dec; 30(6):2531-2539. PubMed ID: 37311914
[TBL] [Abstract][Full Text] [Related]
4. Performance of
Guo H; Wu S; Xiang X; Wang S; Fang Z; Ye Q; Zou Y; Wang Y; Peng D; Ma X
Ann Nucl Med; 2024 Apr; 38(4):288-295. PubMed ID: 38252229
[TBL] [Abstract][Full Text] [Related]
5. Cardiac MRI T1 and T2 Mapping as a Quantitative Imaging Biomarker in Transthyretin Amyloid Cardiomyopathy.
Yamaguchi S; Oda S; Kidoh M; Hayashi H; Takashio S; Usuku H; Nagayama Y; Nakaura T; Tsujita K; Hirai T; Aoki T
Acad Radiol; 2024 Feb; 31(2):514-522. PubMed ID: 37775448
[TBL] [Abstract][Full Text] [Related]
6. Bilateral Multiple Fractures Obstruct Quantitation of 99m Tc-Pyrophosphate Imaging for Cardiac Amyloidosis.
Zhou Q; Zuo J; Xiao L; Jiang L; Zhao Z
Clin Nucl Med; 2024 Jul; 49(7):e362-e363. PubMed ID: 38651782
[TBL] [Abstract][Full Text] [Related]
7. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
[No Abstract] [Full Text] [Related]
8. Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
Takahashi K; Morioka H; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S
J Nucl Cardiol; 2023 Oct; 30(5):2215-2221. PubMed ID: 36352088
[No Abstract] [Full Text] [Related]
9. A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases.
Takahashi K; Iwamura T; Hiratsuka Y; Sasaki D; Yamamura N; Ueda M; Morioka H; Yoshino M; Enomoto D; Uemura S; Okura T; Sakaue T; Ikeda S
Intern Med; 2024 Jun; 63(11):1575-1584. PubMed ID: 37899242
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study.
Spielvogel CP; Haberl D; Mascherbauer K; Ning J; Kluge K; Traub-Weidinger T; Davies RH; Pierce I; Patel K; Nakuz T; Göllner A; Amereller D; Starace M; Monaci A; Weber M; Li X; Haug AR; Calabretta R; Ma X; Zhao M; Mascherbauer J; Kammerlander A; Hengstenberg C; Menezes LJ; Sciagra R; Treibel TA; Hacker M; Nitsche C
Lancet Digit Health; 2024 Apr; 6(4):e251-e260. PubMed ID: 38519153
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of [
Caobelli F; Gözlügöl N; Bakula A; Rominger A; Schepers R; Stortecky S; Hunziker Munsch L; Dobner S; Gräni C
J Nucl Med; 2024 Jun; 65(6):944-951. PubMed ID: 38724281
[TBL] [Abstract][Full Text] [Related]
12. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.
Waheed A; Dorbala S
Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679
[TBL] [Abstract][Full Text] [Related]
13. Deep Learning-Enabled Quantification of
Miller RJH; Shanbhag A; Michalowska AM; Kavanagh P; Liang JX; Builoff V; Fine NM; Dey D; Berman DS; Slomka PJ
J Nucl Med; 2024 May; ():. PubMed ID: 38724278
[TBL] [Abstract][Full Text] [Related]
14. Use of Technetium-99m-Pyrophosphate Single-Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy.
Yu AL; Chen YC; Tsai CH; Wu YA; Su MY; Chou CH; Shun CT; Hsueh HW; Juang JJ; Lee MJ; Tseng PH; Hsu CH; Hsieh ST; Ko CL; Cheng MF; Chao CC; Lin YH
J Am Heart Assoc; 2024 Jan; 13(2):e030512. PubMed ID: 38214277
[TBL] [Abstract][Full Text] [Related]
15. Vicarious excretion of
Kavanaugh M; Shah HJ
J Nucl Cardiol; 2024 May; 35():101814. PubMed ID: 38246258
[TBL] [Abstract][Full Text] [Related]
16. Inverse correlation between age of onset and myocardial amyloid deposition quantified by
Kanaya H; Shiraishi S; Ogasawara K; Iwashita K; Sakamoto F; Takashio S; Mikami Y; Tsujita K; Hirai T
Ann Nucl Med; 2024 Jun; ():. PubMed ID: 38874878
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation.
Yamasaki H; Kondo H; Shiroo T; Iwata N; Masuda T; Makita T; Iwabuchi Y; Tanazawa K; Takahashi M; Ono Y; Ogawa N; Harada T; Mitarai K; Yamauchi S; Takano M; Kodama N; Hirota K; Miyoshi M; Yonezu K; Tawara K; Abe I; Saito S; Fukui A; Fukuda T; Akioka H; Shinohara T; Akiyoshi K; Teshima Y; Yufu K; Daa T; Matsubara E; Asayama Y; Ueda M; Takahashi N
Circ J; 2024 Mar; ():. PubMed ID: 38522901
[TBL] [Abstract][Full Text] [Related]
18. Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
Hansen CL
J Nucl Cardiol; 2023 Dec; 30(6):2418-2426. PubMed ID: 37173549
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.
Castaño A; Manson DK; Maurer MS; Bokhari S
Curr Cardiovasc Risk Rep; 2017 Jun; 11():. PubMed ID: 29057029
[TBL] [Abstract][Full Text] [Related]
20. Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Concurrent Cardiac Amyloidosis: A Technetium Pyrophosphate Study.
Yanagihara T; Hatashima H; Ogata H; Moriuchi Y; Ishimatsu A; Otsuka J; Taguchi K; Moriwaki A; Yoshida M
Cureus; 2024 Mar; 16(3):e56358. PubMed ID: 38633977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
